ClinicalTrialsFinder
RecruitingNCT06982235

Stone and Laser Therapies Post-Market Study (SALT)

Stone and Laser Therapies Post-Market Study

Sponsor

Boston Scientific Corporation

Enrollment

238 participants

Start Date

Jun 30, 2025

Study Type

OBSERVATIONAL

Conditions

Benign Prostate Hypertrophy(BPH)Ureteral Stones, Kidney StonesCalculi, UrinaryUrinary Tract ProcedureRenal calculi

Summary

The objective of the SALT Study is to obtain post-market safety and device performance data for Boston Scientific's Stone and BPH study devices used during a diagnostic and/or therapeutic urinary tract procedure (e.g., transurethral or percutaneous access routes) or benign prostatic hyperplasia (BPH) treatment.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Laser system and a medical device called Ureteroscope system for people with benign prostate hypertrophy(bph), calculi, urinary, and other related conditions. The study is currently recruiting participants at 5 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEUreteroscope system

LithoVue™ Elite Single-Use Digital Flexible Ureteroscope System with intrarenal pressure monitoring

DEVICELaser system

Pulse™ 120H Holmium Laser System with MOSES™ 2.0 Technology

Locations(5)

Mayo Clinic Phoenix

Phoenix, Arizona, United States

University of Miami Hospital

Miami, Florida, United States

University of South Florida

Tampa, Florida, United States

Indiana University Medical Center

Indianapolis, Indiana, United States

Duke University Medical Center

Durham, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06982235

Related Trials

Intraoperative Assessment of of Burst Wave Lithotripsy (BWL)

NCT038732592 locations

Normal vs Low Tidal Volume Ventilation in Retrograde Intrarenal Surgery

NCT076433241 location

Oxiblume:CoQ10 (Ralivia) Therapy for Benign Prostatic Hyperplasia:

NCT076388651 location

Effect of Complete Suction-Induced Collapse of the Renal Collecting System at the End of RIRS on Early Postoperative Outcomes

NCT075352811 location

Using Retrograde Intrarenal Surgery for Managing Staghorn Renal Stones.

NCT073423611 location